Chronic hepatitis C viral infection reduces NK cell frequency and suppresses cytokine secretion: Reversion by anti-viral treatment

Biochemical and Biophysical Research Communications

Volumn 393, Issue 2, 2010, Pages 331-337

  Dessouki, Omar ^a   Kamiya, Yasuyuki ^b   Nagahama, Hiroyasu ^b   Tanaka, Motohiko ^b   Suzu, Shinya ^a   Sasaki, Yutaka ^b   Okada, Seiji ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

CD107a; Hepatitis C; IFN ; Natural killer cells; Subsets

Indexed keywords

ALPHA INTERFERON; CD56 ANTIGEN; CYTOKINE; GAMMA INTERFERON; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN;

ARTICLE; CELL FUNCTION; CELL STIMULATION; CELL STRAIN K 562; CELL SUBPOPULATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; HEPATITIS C; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS RESISTANCE;

ANTIVIRAL AGENTS; CELL DEGRANULATION; CYTOKINES; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; KILLER CELLS, NATURAL; LYMPHOCYTE COUNT; PEPTIDES; POLYETHYLENE GLYCOLS; RECURRENCE; RIBAVIRIN; RNA, VIRAL;

HEPATITIS C VIRUS;

EID: 77649184029     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.02.008     Document Type: Article

References (26)

1. McHutchison J.G. Understanding hepatitis C. Am. J. Manag. Care 10 (2004) S21-S29
2. Hoofnagle J.H. Course and outcome of hepatitis C. Hepatology 36 (2002) S21-S29
3. Biron C.A. Activation and function of natural killer cell responses during viral infections. Curr. Opin. Immunol. 9 (1997) 24-34
4. Crotta S., Stilla A., Wack A., D'Andrea A., Nuti S., D'Oro U., Mosca M., Filliponi F., Brunetto R.M., Bonino F., Abrignani S., and Valiante N.M. Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J. Exp. Med. 195 (2002) 35-41
5. Tseng C.T., and Klimpel G.R. Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J. Exp. Med. 195 (2002) 43-49
6. Li Y., Zhang T., Ho C., Orange J.S., Douglas S.D., and Ho W.Z. Natural killer cells inhibit hepatitis C virus expression. J. Leukoc. Biol. 76 (2004) 1171-1179
7. Gonzalez V.D., Falconer K., Michaelsson J., Moll M., Reichard O., Alaeus A., and Sandberg J.K. Expansion of CD56- NK cells in chronic HCV/HIV-1 co-infection: reversion by antiviral treatment with pegylated IFNalpha and ribavirin. Clin. Immunol. 128 (2008) 46-56
8. Norris S., Collins C., Doherty D.G., Smith F., McEntee G., Traynor O., Nolan N., Hegarty J., and O'Farrelly C. Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes. J. Hepatol. 28 (1998) 84-90
9. Bonorino P., Ramzan M., Camous X., Dufeu-Duchesne T., Thelu M.A., Sturm N., Dariz A., Guillermet C., Pernollet M., Zarski J.P., Marche P.N., Leroy V., and Jouvin-Marche E. Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C. J. Hepatol. 51 (2009) 458-467
10. Ahlenstiel G., Titerence R.H., Koh C., Edlich B., Feld J.J., Rotman Y., Ghany M.G., Hoofnagle J.H., Liang T.J., Heller T., and Rehermann B. Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner. Gastroenterology 138 (2010) 325-335
11. Fried M.W., Shiffman M.L., Reddy K.R., Smith C., Marinos G., Goncales Jr. F.L., Haussinger D., Diago M., Carosi G., Dhumeaux D., Craxi A., Lin A., Hoffman J., and Yu J. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N. Engl. J. Med. 347 (2002) 975-982
12. Hadziyannis S.J., Sette Jr. H., Morgan T.R., Balan V., Diago M., Marcellin P., Ramadori G., Bodenheimer Jr. H., Bernstein D., Rizzetto M., Zeuzem S., Pockros P.J., Lin A., and Ackrill A.M. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann. Intern. Med. 140 (2004) 346-355
13. Sen G.C. Viruses and interferons. Annu. Rev. Microbiol. 55 (2001) 255-281
14. Tilg H. New insights into the mechanisms of interferon alfa: an immunoregulatory and anti-inflammatory cytokine. Gastroenterology 112 (1997) 1017-1021
15. Lechner F., Wong D.K., Dunbar P.R., Chapman R., Chung R.T., Dohrenwend P., Robbins G., Phillips R., Klenerman P., and Walker B.D. Analysis of successful immune responses in persons infected with hepatitis C virus. J. Exp. Med. 191 (2000) 1499-1512
16. Wang S.H., Huang C.X., Ye L., Wang X., Song L., Wang Y.J., Liang H., Huang X.Y., and Ho W.Z. Natural killer cells suppress full cycle HCV infection of human hepatocytes. J. Viral Hepat. 15 (2008) 855-864
17. Alter G., Malenfant J.M., and Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. J. Immunol. Methods 294 (2004) 15-22
18. Penack O., Gentilini C., Fischer L., Asemissen A.M., Scheibenbogen C., Thiel E., and Uharek L. CD56dimCD16neg cells are responsible for natural cytotoxicity against tumor targets. Leukemia 19 (2005) 835-840
19. Grzywacz B., Kataria N., and Verneris M.R. CD56(dim)CD16(+) NK cells downregulate CD16 following target cell induced activation of matrix metalloproteinases. Leukemia 21 (2007) 356-359 author reply 359
20. Nattermann J., Feldmann G., Ahlenstiel G., Langhans B., Sauerbruch T., and Spengler U. Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C. Gut 55 (2006) 869-877
21. Yoon J.C., Shiina M., Ahlenstiel G., and Rehermann B. Natural killer cell function is intact after direct exposure to infectious hepatitis C virions. Hepatology 49 (2009) 12-21
22. De Maria A., Fogli M., Mazza S., Basso M., Picciotto A., Costa P., Congia S., Mingari M.C., and Moretta L. Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients. Eur. J. Immunol. 37 (2007) 445-455
23. Morishima C., Paschal D.M., Wang C.C., Yoshihara C.S., Wood B.L., Yeo A.E., Emerson S.S., Shuhart M.C., and Gretch D.R. Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing. Hepatology 43 (2006) 573-580
24. Foy E., Li K., Sumpter Jr. R., Loo Y.M., Johnson C.L., Wang C., Fish P.M., Yoneyama M., Fujita T., Lemon S.M., and Gale Jr. M. Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. Proc. Natl. Acad. Sci. USA 102 (2005) 2986-2991
25. Foy E., Li K., Wang C., Sumpter Jr. R., Ikeda M., Lemon S.M., and Gale Jr. M. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 300 (2003) 1145-1148
26. Meier U.C., Owen R.E., Taylor E., Worth A., Naoumov N., Willberg C., Tang K., Newton P., Pellegrino P., Williams I., Klenerman P., and Borrow P. Shared alterations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections. J. Virol. 79 (2005) 12365-12374